Ares Trading Sa

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$538Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
153clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2023 $126K
2024 $254K
2025 $157K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Neurology (Psychiatry & Neurology) $417K
Reproductive Endocrinology $39K
Medical Oncology $22K
Neuromuscular Medicine (Psychiatry & Neurology) $21K
Neuromusculoskeletal Medicine, Sports Medicine $18K
Hematology & Oncology $7,193

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Gabriel Pardo Oklahoma City, OK Neurology (Psychiatry & Neurology) $64,068.47
Christopher Laganke Cullman, AL Neurology (Psychiatry & Neurology) $40,623.57
Lucky Sekhon New York, NY Reproductive Endocrinology $38,902.85
Aaron Boster Columbus, OH Neurology (Psychiatry & Neurology) $32,148.66
Donald Negroski Sarasota, FL Neurology (Psychiatry & Neurology) $23,758.37
Jeanie Cote Owosso, MI Neurology (Psychiatry & Neurology) $23,608.63
George Katsamakis Lake Barrington, IL Neurology (Psychiatry & Neurology) $23,173.92
Bruce Hughes Des Moines, IA Neurology (Psychiatry & Neurology) $22,531.30
Ann Bass San Antonio, TX Neurology (Psychiatry & Neurology) $22,531.29
Amparo Gutierrez Orlando, FL Neuromuscular Medicine (Psychiatry & Neurology) $21,393.42

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.